Literature DB >> 17891403

Initial experience with endoscopic third ventriculostomy in Nigeria, West Africa.

Olufemi Idowu1, Alaba Doherty, Ola Tiamiyu.   

Abstract

OBJECTIVES: Endoscopic third ventriculostomy (ETV) as an alternative to traditional shunt surgery in the management of hydrocephalus of different etiologies is new in Nigeria and West Africa, with no published data till date. This initial study was done to determine the success rate and complication among our patient population.
MATERIALS AND METHODS: This series consists of a prospective study of the clinical and radiological features and outcome of the first 25 consecutive patients who underwent ETV. ETV was considered to be successful when there was no event occurring during surgery that resulted in the procedure being aborted, postoperative neurological deficit, or adverse event that resulted in a modification of the normal postoperative care. Patients follow-up was for a minimum of 2 months.
RESULTS: There were 14 males and 11 females. The median age of the patients was 6 months, ranging from 1 month to 48 years. The study included obstructive hydrocephalus because of aqueductal stenosis, Dandy Walker malformation, and pineal region tumor. ETV was successful in 23 patients. Two patients had cerebrospinal fluid leak and superficial surgical site infection. There was no mortality.
CONCLUSION: ETV in this series is safe with comparable surgical outcomes to conventional ventriculoperitoneal shunt surgery, and minimal postoperative morbidity has been observed.

Entities:  

Mesh:

Year:  2007        PMID: 17891403     DOI: 10.1007/s00381-007-0491-6

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  8 in total

Review 1.  Success and failure of endoscopic third ventriculostomy in young infants: are there different age distributions?

Authors:  Dorothee Koch-Wiewrodt; Wolfgang Wagner
Journal:  Childs Nerv Syst       Date:  2006-08-30       Impact factor: 1.475

2.  Success of endoscopic third ventriculostomy in children less than 2 years of age.

Authors:  Volkan Etus; Savas Ceylan
Journal:  Neurosurg Rev       Date:  2005-07-22       Impact factor: 3.042

Review 3.  Endoscopic third ventriculostomy for obstructive hydrocephalus.

Authors:  Dieter Hellwig; Joachim Andreas Grotenhuis; Wuttipong Tirakotai; Thomas Riegel; Dirk Michael Schulte; Bernhard Ludwig Bauer; Helmut Bertalanffy
Journal:  Neurosurg Rev       Date:  2004-11-27       Impact factor: 3.042

4.  The current status of endoscopic third ventriculostomy in the management of non-communicating hydrocephalus.

Authors:  R F Jones; B C Kwok; W A Stening; M Vonau
Journal:  Minim Invasive Neurosurg       Date:  1994-09

5.  Endoscopic third ventriculostomy.

Authors:  R F Jones; W A Stening; M Brydon
Journal:  Neurosurgery       Date:  1990-01       Impact factor: 4.654

6.  Endoscopic third ventriculostomy in pediatric patients: the Canadian experience.

Authors:  James M Drake
Journal:  Neurosurgery       Date:  2007-05       Impact factor: 4.654

7.  Endoscopic fenestration of the 3rd ventricular floor in aqueductal stenosis.

Authors:  U Kunz; A Goldmann; C Bader; H Waldbaur; P Oldenkott
Journal:  Minim Invasive Neurosurg       Date:  1994-12

8.  Endoscopic third ventriculostomy in children younger than 2 years of age.

Authors:  Jörg Baldauf; J Oertel; Michael R Gaab; Henry W S Schroeder
Journal:  Childs Nerv Syst       Date:  2007-04-06       Impact factor: 1.532

  8 in total
  8 in total

1.  Success criteria in pediatric neuroendoscopic procedures. Proposal for classification of results after 67 operations.

Authors:  Bienvenido Ros; Lorena Romero; Guillermo Ibáñez; Sara Iglesias; Francisca Rius; Sandra Pérez; Miguel A Arráez
Journal:  Childs Nerv Syst       Date:  2012-03-14       Impact factor: 1.475

Review 2.  Adult brain tumors in Sub-Saharan Africa: A scoping review.

Authors:  Ulrick Sidney Kanmounye; Claire Karekezi; Arsene Daniel Nyalundja; Ahmed K Awad; Tsegazeab Laeke; James A Balogun
Journal:  Neuro Oncol       Date:  2022-10-03       Impact factor: 13.029

3.  Neurosurgical management of hydrocephalus by a general surgeon in an extremely low resource setting: initial experience in North Kivu province of Eastern Democratic Republic of Congo.

Authors:  Sarah B Cairo; Justice Agyei; Kavira Nyavandu; David H Rothstein; Luc Malemo Kalisya
Journal:  Pediatr Surg Int       Date:  2018-02-16       Impact factor: 1.827

Review 4.  Endoscopic third ventriculostomy with/without choroid plexus cauterization for hydrocephalus due to hemorrhage, infection, Dandy-Walker malformation, and neural tube defect: a meta-analysis.

Authors:  Anthony Zandian; Matthew Haffner; James Johnson; Curtis J Rozzelle; R Shane Tubbs; Marios Loukas
Journal:  Childs Nerv Syst       Date:  2013-12-28       Impact factor: 1.475

5.  Outcome of endoscopic third ventriculostomy and Chhabra shunt system in noncommunicating non-tumor childhood hydrocephalus.

Authors:  O E Idowu; L O Falope; A T Idowu
Journal:  J Pediatr Neurosci       Date:  2009-07

6.  Endoscopic third ventriculostomy in children: problems and surgical outcome: analysis of 34 cases.

Authors:  Md Moshiur Rahman; S I M Khairun Nabi Khan; Robert Ahmed Khan; Rokibul Islam; Mainul Haque Sarker
Journal:  Chin Neurosurg J       Date:  2021-01-06

Review 7.  Limitations of Neuroendoscopic Treatment for Pediatric Hydrocephalus and Considerations from Future Perspectives.

Authors:  Kenichi Nishiyama; Junichi Yoshimura; Yukihiko Fujii
Journal:  Neurol Med Chir (Tokyo)       Date:  2015-07-28       Impact factor: 1.742

Review 8.  Efficacy and safety of flexible versus rigid endoscopic third ventriculostomy in pediatric and adult populations: a systematic review and meta-analysis.

Authors:  Alessandro Boaro; Bhargavi Mahadik; Anthony Petrillo; Francesca Siddi; Sharmila Devi; Shreya Chawla; Abdullah M Abunimer; Alberto Feletti; Alessandro Fiorindi; Pierluigi Longatti; Francesco Sala; Timothy R Smith; Rania A Mekary
Journal:  Neurosurg Rev       Date:  2021-06-25       Impact factor: 2.800

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.